Novartis | Alpha Leaders

Browsing: Novartis

Progress In Fight Against Malaria, As New Treatment Shows Promise

By Press Room1 December 2025

A late stage trial for an investigational malaria drug called GanLum (ganaplacide/lumefantrine) has demonstrated a 97.4% cure rate, outperforming currently…

Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage

By Press Room6 March 2024

Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain adults and…

What's On

Fans Already Have A Cool Theory About The Protagonist For ‘Dragon Quest XII’

The Important Healthcare Model Most People Have Never Heard Of

AI Giants Bet Billions On The Most Expensive Job In Enterprise

Browsing: Novartis

Progress In Fight Against Malaria, As New Treatment Shows Promise

Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage

Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

Exclusive: DeFi platform Azura launches after raising $6.9 million from Initialized

Walmart dominated, while Target spiraled: the winners and losers of retail in 2024

AI Spurs A Cultural Shift In A 1,000-Developer Insurance Company

Today’s Wordle #1804 Hints And Answer For Thursday, May 28

Increased Funding Is Making At-Home Hospital Care A Reality

Founder says he can tell if you’ll stay stuck in the middle class forever with a simple test

Our Picks

Fans Already Have A Cool Theory About The Protagonist For ‘Dragon Quest XII’

The Important Healthcare Model Most People Have Never Heard Of

AI Giants Bet Billions On The Most Expensive Job In Enterprise

Most Popular

Salesforce turbocharges $25 billion stock buying spree with debt, cuts cash flow guidance in half

AI Spurs A Cultural Shift In A 1,000-Developer Insurance Company

Today’s Wordle #1804 Hints And Answer For Thursday, May 28

Archives

Categories